Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+9.01%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$46.3B
AUM Growth
+$5.71B
(+14%)
Cap. Flow
+$2.71B
Cap. Flow
% of AUM
5.85%
Top 10 Holdings %
Top 10 Hldgs %
21.72%
Holding
2,977
New
596
Increased
632
Reduced
646
Closed
724
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.1B |
| 2 |
Microsoft
MSFT
|
+$567M |
| 3 |
Advanced Micro Devices
AMD
|
+$559M |
| 4 |
Amazon
AMZN
|
+$363M |
| 5 |
Apple
AAPL
|
+$353M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$388M |
| 2 |
McDonald's
MCD
|
+$386M |
| 3 |
Visa
V
|
+$380M |
| 4 |
Meta Platforms (Facebook)
META
|
+$371M |
| 5 |
Adobe
ADBE
|
+$330M |
Sector Composition
| 1 | Technology | 21.67% |
| 2 | Healthcare | 18.8% |
| 3 | Consumer Discretionary | 14.72% |
| 4 | Financials | 8.87% |
| 5 | Industrials | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
1826
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $138K | ﹤0.01% |
55,600
-707,776
| -93% | -$1.76M |
|
|
OPTN
1827
DELISTED
OptiNose
OPTN
| $134K | ﹤0.01% |
7,251
+5,262
| +265% | +$97.1K |
|
1828
Playboy, Inc. Common Stock
PLBY
$188M
| $131K | ﹤0.01% |
78,260
-27,089
| -26% | -$45.5K |
|
1829
Pyxis Tankers
PXS
$29.5M
| $129K | ﹤0.01% |
33,998
-15,597
| -31% | -$59K |
|
1830
Atea Pharmaceuticals
AVIR
$261M
| $126K | ﹤0.01% |
+33,674
| New | +$126K |
|
|
USX
1831
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $124K | ﹤0.01% |
20,230
-74,670
| -79% | -$458K |
|
1832
Payoneer
PAYO
$2.4B
| $124K | ﹤0.01% |
25,737
-156,068
| -86% | -$751K |
|
1833
Viant Technology
DSP
$161M
| $122K | ﹤0.01% |
+26,413
| New | +$122K |
|
|
KC
1834
Kingsoft Cloud Holdings
KC
$4.53B
| $120K | ﹤0.01% |
19,691
-125,819
| -86% | -$768K |
|
1835
GrafTech
EAF
$237M
| $118K | ﹤0.01% |
2,350
-5,695
| -71% | -$287K |
|
1836
Traeger
COOK
$185M
| $118K | ﹤0.01% |
27,699
| – | – |
|
|
SACH
1837
Sachem Capital Corp
SACH
$59.7M
| $118K | ﹤0.01% |
33,690
-101,846
| -75% | -$355K |
|
1838
Cullinan Oncology
CGEM
$381M
| $117K | ﹤0.01% |
+10,837
| New | +$117K |
|
|
BIG
1839
DELISTED
Big Lots, Inc.
BIG
| $116K | ﹤0.01% |
+13,160
| New | +$116K |
|
1840
CoreCivic
CXW
$2.27B
| $116K | ﹤0.01% |
+12,342
| New | +$116K |
|
1841
AlTi Global
ALTI
$388M
| $115K | ﹤0.01% |
+14,998
| New | +$115K |
|
1842
CS Disco
LAW
$357M
| $114K | ﹤0.01% |
13,883
-11,370
| -45% | -$93.5K |
|
1843
UWM Holdings
UWMC
$1.53B
| $112K | ﹤0.01% |
+19,955
| New | +$112K |
|
1844
KNOT Offshore Partners
KNOP
$300M
| $110K | ﹤0.01% |
22,327
-23,125
| -51% | -$114K |
|
|
RERE
1845
ATRenew
RERE
$957M
| $110K | ﹤0.01% |
+37,550
| New | +$110K |
|
1846
McEwen Inc.
MUX
$743M
| $105K | ﹤0.01% |
+14,615
| New | +$105K |
|
1847
Ryvyl
RVYL
$9.41M
| $104K | ﹤0.01% |
13,848
-5,070
| -27% | -$38K |
|
1848
Cidara Therapeutics
CDTX
$1.64B
| $101K | ﹤0.01% |
4,466
+3,053
| +216% | +$69K |
|
1849
Atara Biotherapeutics
ATRA
$85.8M
| $100K | ﹤0.01% |
+2,487
| New | +$100K |
|
1850
Ovid Therapeutics
OVID
$91M
| $98.5K | ﹤0.01% |
+30,017
| New | +$98.5K |
|